Physician profile
Michael R Warner
NPI 1942282371
$30,624.71
in general payments reported to CMS, 2019-2025
13 companies · $3,754 in 2025
The $3,754 reported for 2025 was more than what 94% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $128 · 2021: $7,872 · 2022: $6,862 · 2023: $7,097 · 2024: $4,480 · 2025: $3,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,434.92 |
| Food and Beverage | $895.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16,024.01 | 2019-2023 | |
| Abbvie INC. | $13,557.05 | 2019-2025 | |
| Galderma Laboratories, L.P. | $613.77 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $175.06 | 2019-2025 | Libtayo |
| Genzyme Corporation | $66.03 | 2019-2025 | |
| Almirall LLC | $58.71 | 2021-2025 | Klisyri |
| E.R. Squibb & Sons, L.L.C. | $36.54 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $23.54 | 2025 | Zoryve |
| Dusa Pharmaceuticals, INC. | $18.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.94 | 2020 | |
| Vyne Pharmaceuticals INC. | $13.75 | 2020 | |
| Biowound Solutions, INC. | $10.00 | 2025 | Bio-Connekt |
| Biofrontera INC. | $9.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.